My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
HOEC slips on profit booking
Feb 17,2017

Meanwhile, the BSE Sensex was up 184.80 points, or 0.65%, to 28,486.07.

On the BSE, so far 2.38 lakh shares were traded in the counter, compared with average daily volumes of 3.57 lakh shares in the past one quarter. The stock had hit a high of Rs 76.75 and a low of Rs 74.25 so far during the day.

The stock hit a 52-week high of Rs 78.90 on 16 February 2017. The stock hit a 52-week low of Rs 26.55 on 29 February 2016.

The small-cap company has equity capital of Rs 130.49 crore. Face value per share is Rs 10.

Shares of Hindustan Oil Exploration Company (HOEC) rose 8.14% in three trading sessions to settle at Rs 75.70 yesterday, 16 February 2017, from its close of Rs 70 on 13 February 2017.

Shares of HOEC rose 2.37% to end at Rs 75.70 yesterday, 16 February 2017, after the company said it secured two contracts in consortia with Oil India, Prize Petroleum and other private company by the Government of India in the recently concluded bidding for Discovered Small Field Bids Round (DSF 2016). The announcement was made during market hours yesterday, 16 February 2017.

Hindustan Oil Exploration Company (HOEC) reported 30.22% rise in net profit to Rs 4.18 crore on 10.1% rise in net sales to Rs 5.49 crore in Q3 December 2016 over Q3 December 2015.

HOEC has a wholly owned subsidiary, HOEC Bardahl India, engaged in marketing of high performance fuel/engine additives.

Powered by Capital Market - Live News

Repco Home Finance jumps on bargain hunting
Feb 17,2017

Meanwhile, the BSE Sensex was up 186.14 points, or 0.66%, to 28,487.41.

On the BSE, so far 19,000 shares were traded in the counter, compared with average daily volumes of 26,785 shares in the past one quarter. The stock had hit a high of Rs 665.25 and a low of Rs 635.10 so far during the day.

The stock hit a 52-week high of Rs 891.30 on 6 September 2016. The stock hit a 52-week low of Rs 499.50 on 20 December 2016. The stock had underperformed the market over the past 30 days till 16 February 2017, falling 0.89% compared with the 3.83% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 13.19% as against Sensexs 8.23% rise.

The mid-cap company has equity capital of Rs 62.56 crore. Face value per share is Rs 10.

Shares of Repco Home Finance fell 13.06% in three trading sessions to settle at Rs 632.80 yesterday, 16 February 2017, from its close of Rs 727.90 on 13 February 2017.

Net profit of Repco Home Finance rose 20.4% to Rs 46.44 crore on 18.7% rise in operating income to Rs 260.19 crore in Q3 December 2016 over Q3 December 2015.

Repco Home Finance (RHFL) is a professionally managed housing finance company headquartered in Chennai, Tamil Nadu. As at the end of March 2016, RHFL is operating through 120 branches and 31 satellite centres in Tamil Nadu, Andhra Pradesh, Jharkhand, Kerala, Karnataka, Maharashtra, Madhya Pradesh, Gujarat, Odisha, West Bengal and Puducherry.

Powered by Capital Market - Live News

Finolex Cables gains after fund buying
Feb 17,2017

Meanwhile, the S&P BSE Sensex was up 190.73 points, or 0.67%, to 28,495.98

On BSE, so far 22,000 shares were traded in the counter, compared with an average volume of 22,697 shares in the past one quarter. The stock hit a high of Rs 451.55 and a low of Rs 443.05 so far during the day.

The stock hit a 52-week high of Rs 472.15 on 13 February 2017. The stock hit a 52-week low of Rs 224.75 on 17 February 2016. The stock had outperformed the market over the past 30 days till 16 February 2017, rising 5.16% compared with the 3.83% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 12.5% as against Sensexs 8.23% rise.

The small-cap company has an equity capital of Rs 30.59 crore. Face value per share is Rs 2.

Armor Capital Partners LP sold 9.34 lakh shares of Finolex Cables at Rs 437 per share in a bulk deal on BSE yesterday, 16 February 2017.

Separately, SBI Mutual Fund bought 9.40 lakh shares of Finolex Cables at Rs 437 per share in a bulk deal on NSE yesterday, 16 February 2017. Armor Capital Partners LP sold 9.35 lakh shares of Finolex Cables at Rs 437 per share in a bulk deal on NSE yesterday, 16 February 2017.

Finolex Cables net profit rose 37.77% to Rs 68.43 crore on 11.21% rise in total income to Rs 692.26 crore in Q3 December 2016 over Q3 December 2015.

Finolex Cables, the flagship company of the Finolex Group, is Indias largest and leading manufacturer of electrical and telecommunication cables.

Powered by Capital Market - Live News

Cipla gains after launching Hepatitis B vaccine in India
Feb 17,2017

The announcement was made during trading hours today, 17 February 2017.

Meanwhile, the BSE Sensex was up 203.30 points, or 0.72%, to 28,504.57.

On the BSE, so far 1.44 lakh shares were traded in the counter, compared with average daily volumes of 97,473 shares in the past one quarter. The stock had hit a high of Rs 596.25 and a low of Rs 581.70 so far during the day.

The stock hit a 52-week high of Rs 621.90 on 6 February 2017. The stock hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had underperformed the market over the past 30 days till 16 February 2017, rising 0.31% compared with the 3.83% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 6.12% as against Sensexs 8.23% rise.

The large-cap pharmaceutical company has equity capital of Rs 160.89 crore. Face value per share is Rs 2.

Cipla announced that it has launched adult Hepatitis B vaccine in India. Under a co-exclusive agreement with Serum Institute of India (SII), Cipla will market the vaccine for adults while SII will market it for adults and children.

Serum Institute of India is the worlds second largest vaccine manufacturer in number of doses manufactured and supplied to more than 140 countries.

Umang Vohra, MD and Global CEO Cipla said that this agreement will enable Cipla to provide affordable vaccines for a chronic disease like Hepatitis B. Ciplas strong marketing network and reach will ensure maximum accessibility of the vaccines in India.

In India, around 40 million people are chronically infected with Hepatitis B. This infection is responsible for 70% of chronic Hepatitis and 80% of liver cirrhosis. Hepatitis B is spread through contact with an infected persons blood and body fluids. At risk are all those who are not vaccinated against the infection. Since 2002 the Hepatitis B vaccine has been a part of Indias Universal Immunization Programme. This vaccine is able to protect 95% of recipients from developing chronic Hepatitis B. The vaccine is given in three doses that include one after the first month of the first dose and the second after 6 months post the first dose. The vaccine can protect the recipient from this infection for decades. In addition, it is expected to bring down the number of cases of liver cirrhosis and liver cancer.

Ciplas consolidated net profit rose 43.85% to Rs 374.83 crore on 15.64% rise in net sales to Rs 3550.02 crore in Q3 December 2016 over Q3 December 2015.

Cipla is a global pharmaceutical company. Its portfolio includes over 1000 products across wide range of therapeutic categories.

Powered by Capital Market - Live News

Stronger collaboration between Asia Pacific countries key to empowerment and digital transformation
Feb 17,2017

n++Networks are the key to transforming India into a knowledge based society and a digital economyn++, pointed out Mr P P Chaudhary, Union Minister of State for Law and Justice and Electronics and Information Technology.

The Minister emphasized upon Indias strong position at the digital frontier, riding on the back of the National Digital India Mission, the Jan Dhan-Aadhar-Mobile (JAM) trinity, the role of Direct Benefits Transfer in reaching welfare schemes to the poor and a robust e-Governance infrastructure enabling delivery of citizen centric services to the last mile. He also pointed out the dynamic role played by the Village Level Entrepreneurs in empowering the villages of India and fostering social inclusion.

Inviting international collaboration on high quality research on digital technology, Dr Ajay Kumar, Additional Secretary, Ministry of Electronics & Information Technology, Government of India said that the Asia Pacific region comprises the vortex of internet activities and it is essential to create strong linkages through a number of collaborative efforts like the Visvesvaraya PhD Scheme and Global Innovation and Technology Alliance (GITA), that are supported by the Government of India. He called upon the Asian Pacific countries to play a greater role in global internet governance policy making through greater collaboration and participation.

Dr Neena Pahuja, Director General, ERNET highlighted that technology has helped in creating transparency & disruptive changes. With the base of high speed advanced networks, we are now on the verge of witnessing another wave of disruptive change both in industry and also in day-to-day lifes. In Industry, the connected environment is helping in better productivity and applications such as preventive healthcare, disaster mitigation, remote soil health check-ups are now becoming reality.

She added that India has very big plans to empower every citizen with access to digital services, knowledge and information, and is investing in large scale connected environment. The ambitious project of creating 100 Smart Cities in India will also ride on strongly connected cities.

Mr Bhaskar Pramanik, Chairman, CII National Committee on IT & ITeS and Chairman, Microsoft Corporation said that the digital revolution was reminiscent of the Industrial revolution and would have major impact on the social fabric, healthcare, education system and a plethora of sectors including agriculture, defense, MSME, skills, among others. n++Technology should flow from the technocrats to the people who turn the wheels of the economyn++, he said. He also laid emphasis upon industry - academia collaboration that will take the digital revolution, a step further.

Powered by Capital Market - Live News

Karur Vysya Bank turns volatile after huge bulk deal
Feb 17,2017

Meanwhile, the S&P BSE Sensex was up 167.37 points, or 0.59%, to 28,468.64

On BSE, so far 2.42 crore shares were traded in the counter, compared with average daily volume of 67,396 shares in the past one quarter. The stock saw high intraday volatility. The stock hit a high of Rs 94.80 and a low of Rs 91 so far during the day. The stock hit a 52-week high of Rs 108.28 on 11 July 2016. The stock hit a 52-week low of Rs 78.78 on 29 February 2016.

The mid-cap private sector bank has equity capital of Rs 121.86 crore. Face value per share is Rs 2.

Karur Vysya Banks net profit dropped 24.26% to Rs 115.76 crore on 3.68% rise in total income to Rs 1581.26 crore in Q3 December 2016 over Q3 December 2015.

Karur Vysya Bank has 667 branches and 1655 ATMs as on 31 March 2016.

Powered by Capital Market - Live News

Venus Remedies spurts on QIP plan
Feb 17,2017

The announcement was made during trading hours today, 17 February 2017.

Meanwhile, the BSE Sensex was up 166.87 points, or 0.59%, to 28,468.14.

On the BSE, so far 1.67 lakh shares were traded in the counter, compared with average daily volumes of 31,821 shares in the past one quarter. The stock had hit a high of Rs 106.40 and a low of Rs 95 so far during the day.

The stock hit a 52-week high of Rs 142.80 on 5 October 2016. The stock hit a 52-week low of Rs 65 on 1 June 2016. The stock had underperformed the market over the past 30 days till 16 February 2017, falling 9.07% compared with the 3.83% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 11.54% as against Sensexs 8.23% rise.

The small-cap company has equity capital of Rs 11.44 crore. Face value per share is Rs 10.

Venus Remedies reported net loss of Rs 2.10 crore in Q3 December 2016 as against net loss of Rs 0.25 crore in Q3 December 2015. Net sales declined 12.61% to Rs 84.49 crore in Q3 December 2016 over Q3 December 2015.

Venus Remedies is a pharmaceutical company.

Powered by Capital Market - Live News

Board of Modison Metals recommends dividend
Feb 17,2017

Modison Metals announced that the Board of Directors of the Company at its meeting held on 17 February 2017, inter alia, have recommended the dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

HCL Technologies named Leader for Life Sciences IT Application Services
Feb 17,2017

HCL Technologies continues to be recognized for its global leadership in life sciences IT services and solutions. Everest Group, in its report Life Sciences IT Application Services - Service Provider Landscape with PEAK MatrixTM Assessment 2016n++ named HCL among leaders, recognizing HCLs wide range of application services solutions across all value chain elements of life sciences practice.

Powered by Capital Market - Live News

Fredun Pharmaceuticals to hold board meeting
Feb 17,2017

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24 February 2017, to discuss, consider and approve the matter of the Increasing Authorised Capital of the Company.

Powered by Capital Market - Live News

Central Bank of India announces appointment of director
Feb 17,2017

Central Bank of India announced that in terms of Government of India, Ministry of Finance Notification dated 16 February 2017, P. Ramana Murthy, General Manager of Allahabad Bank has been appointed as Executive Director of the Bank for a period of 3 years w.e.f. the date of his taking over charge of the post i.e. 17 February 2017, or until further orders, whichever is earlier.

Powered by Capital Market - Live News

Syncom Healthcare reports standalone net loss of Rs 7.21 crore in the December 2016 quarter
Feb 17,2017

Net Loss of Syncom Healthcare reported to Rs 7.21 crore in the quarter ended December 2016 as against net loss of Rs 0.25 crore during the previous quarter ended December 2015. Sales declined 3.96% to Rs 13.09 crore in the quarter ended December 2016 as against Rs 13.63 crore during the previous quarter ended December 2015.

ParticularsQuarter Endedn++Dec. 2016Dec. 2015% Var. Sales13.0913.63 -4 OPM %-8.71-5.87 - PBDT-1.14-1.58 28 PBT-2.26-2.61 13 NP-7.21-0.25 -2784

Powered by Capital Market - Live News

Innoventive Industries reports standalone net loss of Rs 0.08 crore in the December 2016 quarter
Feb 17,2017

Net Loss of Innoventive Industries reported to Rs 0.08 crore in the quarter ended December 2016 as against net loss of Rs 0.01 crore during the previous quarter ended December 2015. There were no Sales reported in the quarter ended December 2016 and during the previous quarter ended December 2015.

Powered by Capital Market - Live News

Indo Pacific Projects reports standalone net loss of Rs 0.22 crore in the December 2016 quarter
Feb 17,2017

Net loss of Indo Pacific Projects reported to Rs 0.22 crore in the quarter ended December 2016 as against net profit of Rs 0.24 crore during the previous quarter ended December 2015. Sales declined 55.03% to Rs 0.76 crore in the quarter ended December 2016 as against Rs 1.69 crore during the previous quarter ended December 2015.

ParticularsQuarter Endedn++Dec. 2016Dec. 2015% Var. Sales0.761.69 -55 OPM %-28.9520.12 - PBDT-0.220.35 PL PBT-0.220.35 PL NP-0.220.24 PL

Powered by Capital Market - Live News

O.P Chains reports standalone net loss of Rs 0.05 crore in the December 2016 quarter
Feb 17,2017

Net loss of O.P Chains reported to Rs 0.05 crore in the quarter ended December 2016 as against net profit of Rs 0.05 crore during the previous quarter ended December 2015. Sales declined 86.33% to Rs 1.49 crore in the quarter ended December 2016 as against Rs 10.90 crore during the previous quarter ended December 2015.

ParticularsQuarter Endedn++Dec. 2016Dec. 2015% Var. Sales1.4910.90 -86 OPM %-4.030.73 - PBDT-0.060.08 PL PBT-0.070.07 PL NP-0.050.05 PL

Powered by Capital Market - Live News